Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2021-09-24 20:54:55 UTC
Update Date2021-09-24 20:54:55 UTC
HMDB IDHMDB0304887
Secondary Accession NumbersNone
Metabolite Identification
Common NameEncorafenib
DescriptionEncorafenib belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. Encorafenib is a drug which is used in combination with [binimetinib] in metastatic melanoma with a braf v600e or v600k mutation, as detected by an fda-approved test [l3335]. Based on a literature review very few articles have been published on Encorafenib.
Structure
Thumb
Synonyms
ValueSource
NVP-LGX818ChEMBL
LGX-818ENCORAFENIBChEMBL
NVP-LGX818-NXAChEMBL
Chemical FormulaC22H27ClFN7O4S
Average Molecular Weight540.01
Monoisotopic Molecular Weight539.1517794
IUPAC Namemethyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamate
Traditional Namemethyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-isopropylpyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamate
CAS Registry NumberNot Available
SMILES
COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C
InChI Identifier
InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1
InChI KeyCMJCXYNUCSMDBY-ZDUSSCGKSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassAzoles
Sub ClassPyrazoles
Direct ParentPhenylpyrazoles
Alternative Parents
Substituents
  • Phenylpyrazole
  • Sulfanilide
  • Aminopyrimidine
  • Chlorobenzene
  • Fluorobenzene
  • Halobenzene
  • Benzenoid
  • Organosulfonic acid amide
  • Organic sulfonic acid amide
  • Pyrimidine
  • Aryl fluoride
  • Aryl halide
  • Monocyclic benzene moiety
  • Aryl chloride
  • Aminosulfonyl compound
  • Carbamic acid ester
  • Sulfonyl
  • Organosulfonic acid or derivatives
  • Organic sulfonic acid or derivatives
  • Heteroaromatic compound
  • Methylcarbamate
  • Azacycle
  • Organic oxygen compound
  • Organochloride
  • Organohalogen compound
  • Organofluoride
  • Amine
  • Carbonyl group
  • Organonitrogen compound
  • Organooxygen compound
  • Organosulfur compound
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
DispositionNot Available
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.16ALOGPS
logP2.65ChemAxon
logS-4.7ALOGPS
pKa (Strongest Acidic)8.45ChemAxon
pKa (Strongest Basic)3.08ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area140.13 ŲChemAxon
Rotatable Bond Count9ChemAxon
Refractivity145.6 m³·mol⁻¹ChemAxon
Polarizability54.11 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+222.13932859911
AllCCS[M+H-H2O]+220.52132859911
AllCCS[M+Na]+224.02432859911
AllCCS[M+NH4]+223.60732859911
AllCCS[M-H]-218.84632859911
AllCCS[M+Na-2H]-220.44232859911
AllCCS[M+HCOO]-222.33932859911
DeepCCS[M+H]+212.35930932474
DeepCCS[M-H]-209.96330932474
DeepCCS[M-2H]-242.89130932474
DeepCCS[M+Na]+218.27230932474

Predicted Kovats Retention Indices

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Encorafenib,1TMS,isomer #1COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C4103.1Semi standard non polar33892256
Encorafenib,1TMS,isomer #1COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C4001.6Standard non polar33892256
Encorafenib,1TMS,isomer #1COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C6130.7Standard polar33892256
Encorafenib,1TMS,isomer #2COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C4132.0Semi standard non polar33892256
Encorafenib,1TMS,isomer #2COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C4064.2Standard non polar33892256
Encorafenib,1TMS,isomer #2COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C6025.5Standard polar33892256
Encorafenib,1TMS,isomer #3COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N13989.0Semi standard non polar33892256
Encorafenib,1TMS,isomer #3COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N14011.9Standard non polar33892256
Encorafenib,1TMS,isomer #3COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N16147.9Standard polar33892256
Encorafenib,2TMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C4015.3Semi standard non polar33892256
Encorafenib,2TMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C4179.4Standard non polar33892256
Encorafenib,2TMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C5509.4Standard polar33892256
Encorafenib,2TMS,isomer #2COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C3930.4Semi standard non polar33892256
Encorafenib,2TMS,isomer #2COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C4161.7Standard non polar33892256
Encorafenib,2TMS,isomer #2COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C5684.7Standard polar33892256
Encorafenib,2TMS,isomer #3COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C3914.6Semi standard non polar33892256
Encorafenib,2TMS,isomer #3COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C4211.3Standard non polar33892256
Encorafenib,2TMS,isomer #3COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C5573.6Standard polar33892256
Encorafenib,3TMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C3913.5Semi standard non polar33892256
Encorafenib,3TMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C4345.7Standard non polar33892256
Encorafenib,3TMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C5182.3Standard polar33892256
Encorafenib,1TBDMS,isomer #1COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C4287.1Semi standard non polar33892256
Encorafenib,1TBDMS,isomer #1COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C4237.9Standard non polar33892256
Encorafenib,1TBDMS,isomer #1COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C6020.4Standard polar33892256
Encorafenib,1TBDMS,isomer #2COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C4283.4Semi standard non polar33892256
Encorafenib,1TBDMS,isomer #2COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C4287.7Standard non polar33892256
Encorafenib,1TBDMS,isomer #2COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C5918.5Standard polar33892256
Encorafenib,1TBDMS,isomer #3COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N14169.9Semi standard non polar33892256
Encorafenib,1TBDMS,isomer #3COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N14236.9Standard non polar33892256
Encorafenib,1TBDMS,isomer #3COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N16064.4Standard polar33892256
Encorafenib,2TBDMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4333.4Semi standard non polar33892256
Encorafenib,2TBDMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4635.4Standard non polar33892256
Encorafenib,2TBDMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C5430.8Standard polar33892256
Encorafenib,2TBDMS,isomer #2COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C4249.0Semi standard non polar33892256
Encorafenib,2TBDMS,isomer #2COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C4635.6Standard non polar33892256
Encorafenib,2TBDMS,isomer #2COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C5611.0Standard polar33892256
Encorafenib,2TBDMS,isomer #3COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C4213.7Semi standard non polar33892256
Encorafenib,2TBDMS,isomer #3COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C4671.2Standard non polar33892256
Encorafenib,2TBDMS,isomer #3COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C5492.3Standard polar33892256
Encorafenib,3TBDMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C4369.4Semi standard non polar33892256
Encorafenib,3TBDMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C5043.3Standard non polar33892256
Encorafenib,3TBDMS,isomer #1COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C5176.3Standard polar33892256
Spectra

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 10V, Positive-QTOFsplash10-00kg-1101960000-294b6111f39f0027aa802017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 20V, Positive-QTOFsplash10-014i-1202900000-33203f13d78f5ea841682017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 40V, Positive-QTOFsplash10-0gbj-4529600000-984e4a891f3cfdec2b852017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 10V, Negative-QTOFsplash10-0a70-8000290000-b402052b5abd968425212017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 20V, Negative-QTOFsplash10-004i-9000410000-91a972e1956be72f63792017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 40V, Negative-QTOFsplash10-004i-9000000000-85f441a29bc523826a372017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 10V, Positive-QTOFsplash10-0006-0000490000-44859e41739028e805822021-10-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 20V, Positive-QTOFsplash10-00ry-0000920000-2a257f954a3d22bd6de32021-10-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 40V, Positive-QTOFsplash10-00gi-2005900000-4a0031e6257cfff814ea2021-10-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 10V, Negative-QTOFsplash10-0019-1000980000-f939ef58c353a4e096dc2021-10-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 20V, Negative-QTOFsplash10-0080-1001900000-7650b6a8f6881886a7b72021-10-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Encorafenib 40V, Negative-QTOFsplash10-0077-9205810000-48e23cae564fa984d0212021-10-22Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11718
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID28536139
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available